Prostatic Neoplasms: all 6,484 studies
Page 64 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.
- Study Using CP-461 to Treat Advanced Prostate CancerCompletedNCT00036075Phase 2
- Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone MetastasisCompletedNCT00035997Phase 4
- Follow-Up Study for Men Diagnosed With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening ProgramCompletedNCT00035217
- EPO906 Therapy in Patients With Prostate CancerCompletedNCT00035113Phase 2
- Ketoconazole Plus Docetaxel to Treat Prostate CancerCompletedNCT00032825Phase 1
- Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate CancerCompletedNCT00032058Not applicable
- Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate CancerCompletedNCT00032006Phase 2
- Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate CancerCompletedNCT00031889Phase 2
- Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen LevelsCompletedNCT00031746Phase 2
- 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedNCT00031681Phase 1
- Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate CancerCompletedNCT00031187Phase 2
- Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate CancerCompletedNCT00030654Phase 3
- Vaccine Therapy in Treating Patients With Recurrent Prostate CancerCompletedNCT00030602Phase 2
- Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1
- Ultrasound in Treating Patients With Prostate Cancer Confined to the ProstateCompletedNCT00030290Phase 1
- High-Intensity Focused Ultrasound in Treating Patients With Locally Recurrent Prostate CancerCompletedNCT00030277Phase 1
- Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone LesionsCompletedNCT00029224Phase 4
- Gabapentin in Treating Hot Flashes in Patients With Prostate CancerCompletedNCT00028574Phase 3
- Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate CancerCompletedNCT00027859Phase 3
- Radical Prostatectomy in Treating Patients With Locally Advanced Prostate CancerCompletedNCT00027794Phase 2
- MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00027781Phase 2
- APC8015 and Bevacizumab in Treating Patients With Prostate CancerCompletedNCT00027599Phase 2
- SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate CancerCompletedNCT00026377Phase 1
- Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate CancerCompletedNCT00025194Phase 1/2
- ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00025116Phase 2
- DHA-Paclitaxel in Treating Patients With Metastatic Prostate CancerStatus unknownNCT00024414Phase 2
- Monoclonal Antibody Therapy in Treating Patients With Prostate CancerCompletedNCT00024232Phase 2
- SU006668 in Treating Patients With Advanced Solid TumorsStatus unknownNCT00024063Phase 1
- Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate CancerCompletedNCT00023829Phase 3
- Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate CancerCompletedNCT00023686Phase 3
- S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian CancerTerminatedNCT00023634Phase 1
- Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic MethodsCompletedNCT00022919
- Doxercalciferol Before Surgery in Treating Localized Prostate CancerCompletedNCT00022412Phase 2
- Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate CancerCompletedNCT00022399Phase 2
- Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate CancerCompletedNCT00021450Phase 3
- Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate CancerCompletedNCT00020995Phase 2
- CT Scans in Guiding the Treatment of Patients With Prostate Cancer Who Are Undergoing Radiation TherapyCompletedNCT00020891Phase 2
- Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate CancerCompletedNCT00020735Phase 2
- Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate CancerCompletedNCT00020254Phase 2
- Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate CancerCompletedNCT00020046Phase 2
- Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate CancerTerminatedNCT00019695Phase 2
- Flavopiridol in Treating Patients With Refractory CancerCompletedNCT00019344Phase 1
- Calcifidol Therapy in Men With CancerCompletedNCT00018538Phase 2
- Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00017576Phase 2
- BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00016393Phase 2
- Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate CancerCompletedNCT00016146Phase 1
- Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate CancerCompletedNCT00016107Phase 2
- Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00015977Phase 2
- Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate CancerTerminatedNCT00014586Phase 3
- Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid TumorsCompletedNCT00014456Phase 1
- Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate CancerCompletedNCT00014352Phase 2
- Facilitating Shared Decisionmaking About Prostate Cancer ScreeningCompletedNCT00013247Not applicable
- Treatment Decision Intervention for Veterans With Prostate CancerCompletedNCT00012935Not applicable
- CCI-779 in Treating Patients With Prostate CancerCompletedNCT00012142Phase 2
- Early Stage Prostate Cancer CohortCompletedNCT00011349
- Comparison of Radiation Therapy Regimens in Treating Patients With Localized Prostate CancerCompletedNCT00010244Phase 3
- Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00010231Phase 1
- Vaccine Therapy in Treating Patients With Metastatic Prostate CancerTerminatedNCT00010127Phase 1
- Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyStatus unknownNCT00009750Phase 1
- To Explore Racial Differences in Potential Risk Factors for Developing Prostate Cancer in the VA Population.CompletedNCT00007579
- Study of Prostate Cancer in Black and White U.S. VeteransCompletedNCT00007540
- A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNAStatus unknownNCT00006430Phase 1
- Monoclonal Antibody Therapy in Treating Patients With Prostate CancerCompletedNCT00006380Phase 1
- A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate CancerTerminatedNCT00006371Phase 2
- External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate CancerCompletedNCT00006365Phase 2
- Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate CancerCompletedNCT00006359Phase 2
- Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the ProstateCompletedNCT00006214Phase 2
- Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyStatus unknownNCT00006114Phase 2
- Lycopene In Preventing of Prostate CancerCompletedNCT00006078Phase 1
- Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone TherapyCompletedNCT00006044Phase 1
- Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00006023Phase 2
- Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate CancerCompletedNCT00006019Phase 2
- SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00006002Phase 2
- Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyStatus unknownNCT00005992Phase 1
- Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyStatus unknownNCT00005960Phase 2
- Brachytherapy in Treating Patients With Recurrent Prostate CancerStatus unknownNCT00005939Phase 1/2
- PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate CancerCompletedNCT00005916Phase 2
- Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone TherapyCompletedNCT00005857Phase 2
- R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00005848Phase 2
- Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00005847Phase 2
- Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00005828Phase 2
- Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate CancerWithdrawnNCT00005827Phase 1
- Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00005820Phase 2
- Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00005810Phase 2
- Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous TherapyCompletedNCT00005634Phase 1
- Vaccine Therapy Plus QS21 in Treating Patients With Prostate CancerCompletedNCT00005632Phase 1
- Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00005627Phase 1
- Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate CancerCompletedNCT00005623Phase 3
- Docetaxel in Treating Patients With Stage II or Stage III Prostate CancerCompletedNCT00005096Phase 2
- Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate CancerTerminatedNCT00005075Phase 3
- Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No SymptomsTerminatedNCT00005073Phase 3
- Leuvectin in Treating Patients With Locally Recurrent Prostate CancerTerminatedNCT00005072Phase 1/2
- Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate CancerTerminatedNCT00005067Phase 1
- Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00005048Phase 1
- Vaccine Therapy in Treating Patients With Advanced Adenocarcinoma of the Prostate (Prostate Cancer)TerminatedNCT00005039Phase 2
- Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate CancerCompletedNCT00005028Phase 2
- Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate CancerCompletedNCT00004929Phase 1
- Calcitriol and Zoledronate in Treating Patients With Progressive Prostate CancerCompletedNCT00004928Phase 1
- Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction CancerCompletedNCT00004879Phase 1
- EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue SarcomaTerminatedNCT00004261Phase 1